Project Grant R01AI192139
Award Date 9/25/25
Completion Date 8/31/29
Dollars Obligated $2.9M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $812,427 to the University of California, San Diego (UCSD) to develop an interactive online data dashboard. The dashboard will integrate de-identified and aggregated HIV sequence data with publicly available Ending the HIV Epidemic (EHE) prevention and treatment data to identify regions with heightened HIV...
- The University of California, San Diego (UCSD) was awarded a $3,194,992.00 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, awarded on July 16, 2025, supports research to study the roles and regulation of tissue-resident CD8 T cells during a persistent viral infection. The research aims to investigate the mechanisms that allow immune cells to adapt and maintain a long-term...
- The University of California, San Diego (UCSD) received a $702,788 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), to establish the San Diego Implementation Science Hub (SD IS Hub). The SD IS Hub applies implementation science principles to support the objectives of the NIH Ending the HIV Epidemic (EHE) initiative by providing technical consultation and support to...
- The University of Chicago was awarded a $295,276 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), to computationally investigate key morphological transitions in the HIV-1 life cycle. The research aims to develop a mechanistic understanding of viral assembly, maturation, and uncoating processes, which could aid in the design of new antiretroviral therapies targeting...
- The University of California, San Diego (UCSD) was awarded a $4,874,620 Cooperative Agreement from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support a binational cohort study to prospectively examine the intersection of substance use, HIV, and associated comorbidities among people who inject drugs in the San Diego region. Key objectives include characterizing trends and predictors of established and emerging...
- This Project Grant award of $285,816 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research to enhance understanding of ADP-ribosylation (ADPR) and its role in HIV-1 latency and reactivation. The awardee, The Regents of the University of California, San Francisco, will conduct biochemical, proteomic, and cellular assays to identify global proteomic changes to ADPR during HIV-1 latency and reactivation,...
- The University of Chicago received a $126,435 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to pilot the implementation of electronic patient-reported sexual health data into electronic medical records (EMRs) to identify individuals who would benefit from pre-exposure prophylaxis (PrEP) for HIV prevention. The project, titled "INFOHIV: Clinical Informatics for Optimizing HIV Prevention and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,972 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation for the State University of New York, doing business as Sponsored Projects Services, to study the role of the cellular protein EHD4 in restricting HIV-1 infection. The research aims to determine the mechanism by which EHD4 decreases the infectivity of HIV-1 particles by impacting the incorporation of...
- The University of California, San Diego (UCSD) was awarded a $2,223,769 Project Grant from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), with an award date of April 15, 2025 and an ultimate completion date of January 31, 2030. The grant will fund a comprehensive investigation to uncover the mechanistic intersection through which HIV and opioids heighten inflammation, with the goal of offering insights for targeted interventions...
- The U.S. Department of Health and Human Services' HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) awarded a $1,702,777.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on July 1, 2025. The grant supports UCSF's comprehensive efforts to prevent, diagnose, and address HIV transmission through targeted community-based interventions, with a focus on developing and implementing effective HIV prevention strategies for high-risk...